Atopic Dermatitis

Published on 05/03/2015 by admin

Filed under Dermatology

Last modified 05/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 4538 times

10

Atopic Dermatitis

Introduction

Common inflammatory skin disease that affects 10–25% of children and 2–10% of adults in most high-income and some low-income countries.

Eczematous dermatitis characterized by intense pruritus and a chronic or chronically relapsing course.

Sequelae often include sleep disturbances, psychological distress, disrupted family dynamics, and impaired functioning at school or work.

Onset usually in infancy or early childhood, with development in the first year of life in >50% and before 5 years of age in >85% of affected individuals.

Often accompanied by other atopic disorders such as asthma and allergic rhinoconjunctivitis (hay fever), which develop in an age-dependent sequence referred to as the atopic march (Fig. 10.1).

image

Fig. 10.1 The atopic march.

Atopy is linked to the presence of allergen-specific serum IgE antibodies, which exist in ~70% of individuals who meet diagnostic criteria for atopic dermatitis (AD) (Table 10.1).

The ‘hygiene hypothesis’ postulates that decreased exposure to infectious agents in early childhood increases susceptibility to atopic diseases.

Both a genetic predisposition and environmental triggers (e.g., irritation, epicutaneous sensitization, microbial colonization) have pathogenic roles in AD.

Loss-of-function variants in the filaggrin gene (FLG), which encodes a protein important to epidermal barrier function, represent a major predisposing factor for AD that is present in 20–50% of AD patients of European or Asian descent; these FLG variants are also implicated in ichthyosis vulgaris.

Clinical Features and Disease Stages of AD

Pruritic eczematous lesions are often excoriated and exist on a spectrum of acuity:

Acute lesions: edematous, erythematous papules and plaques that may have vesiculation, oozing, and crusting.

Subacute lesions: erythematous patches or plaques with scaling and variable crusting.

Chronic lesions: thickened plaques with lichenification (increased skin markings) as well as scaling.

Small perifollicular papules (papular eczema) are especially common in patients with darkly pigmented skin.

Regional variants of AD are depicted in Fig. 10.2.

Post-inflammatory hyper-, hypo-, or (in severe cases) depigmentation may be seen upon resolution of AD lesions (Fig. 10.3).

DDx: outlined in Table 10.2.

AD is divided into infantile, childhood, and adolescent/adult stages with characteristic morphologies and distributions (see Fig. 10.2).